Neogen Corporation Unrealized Gain (Loss) on Derivatives
Neogen Corporation (NEOG) reported Unrealized Gain (Loss) on Derivatives of $200.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2026-07-30
- Neogen Corporation unrealized gain (loss) on derivatives for the quarter ending 2026-05-31 was $200.00K.
- Neogen Corporation unrealized gain (loss) on derivatives for the quarter ending 2026-02-28 was $100.00K.
- Neogen Corporation unrealized gain (loss) on derivatives for the quarter ending 2025-11-30 was $11.00K, a 97.22% decline year-over-year.
- Neogen Corporation unrealized gain (loss) on derivatives for the quarter ending 2025-08-31 was -$127.00K.
- Neogen Corporation unrealized gain (loss) on derivatives for fiscal 2026 was $200.00K.
- Neogen Corporation unrealized gain (loss) on derivatives for fiscal 2025 was -$1.00M, a 183.33% decline from fiscal 2024.
- Neogen Corporation unrealized gain (loss) on derivatives for fiscal 2024 was $1.20M.
- Neogen Corporation unrealized gain (loss) on derivatives for fiscal 2023 was -$644.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 3 month as first filed | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 9 month as first filed | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $300.00K derived: sum of 2 quarters · filed 2026-07-30 | $311.00K derived: sum of 3 quarters · filed 2026-07-30 | $200.00K 10-K · filed 2026-07-30 | |||
| 2026-02-28 | $100.00K 10-Q · filed 2026-04-09 | $111.00K derived: sum of 2 quarters · filed 2026-04-09 | $0.00 10-Q · filed 2026-04-09 | -$116.00K derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-11-30 | $11.00K 10-Q · filed 2026-01-08 | -$117.00K 10-Q · filed 2026-01-08 | -$216.00K derived: sum of 3 quarters · filed 2026-07-30 | -$316.00K derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-08-31 | -$127.00K 10-Q · filed 2025-10-09 | -$227.00K derived: sum of 2 quarters · filed 2026-07-30 | -$327.00K derived: sum of 3 quarters · filed 2026-07-30 | $68.00K derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-05-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$200.00K derived: sum of 2 quarters · filed 2026-07-30 | $195.00K derived: sum of 3 quarters · filed 2026-07-30 | -$1.00M 10-K · filed 2026-07-30 | -$987.00K 10-K · filed 2025-07-30 | ||
| 2025-02-28 | -$100.00K 10-Q · filed 2026-04-09 | -$91.00K 10-Q · filed 2025-04-09 | $295.00K derived: sum of 2 quarters · filed 2026-04-09 | -$900.00K 10-Q · filed 2026-04-09 | -$914.00K 10-Q · filed 2025-04-09 | -$298.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2024-11-30 | $395.00K 10-Q · filed 2026-01-08 | -$823.00K 10-Q · filed 2026-01-08 | -$198.00K derived: sum of 3 quarters · filed 2026-07-30 | -$154.00K derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2024-08-31 | -$926.00K 10-Q · filed 2025-10-09 | -$593.00K derived: sum of 2 quarters · filed 2026-07-30 | -$549.00K derived: sum of 3 quarters · filed 2026-07-30 | -$660.00K derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2024-05-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $377.00K derived: sum of 2 quarters · filed 2026-07-30 | $266.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.20M 10-K · filed 2026-07-30 | $1.23M 10-K · filed 2024-07-30 | ||
| 2024-02-29 | $44.00K 10-Q · filed 2025-04-09 | -$67.00K derived: sum of 2 quarters · filed 2025-04-09 | $867.00K 10-Q · filed 2025-04-09 | $51.00K derived: sum of 4 quarters · filed 2025-07-30 | |||
| 2023-11-30 | -$111.00K 10-Q · filed 2025-01-15 | $111.00K 10-Q · filed 2024-01-09 | $822.00K 10-Q · filed 2025-01-15 | $7.00K derived: sum of 3 quarters · filed 2025-07-30 | $935.00K derived: sum of 4 quarters · filed 2025-07-30 | ||
| 2023-08-31 | $933.00K 10-Q · filed 2024-10-10 | $118.00K derived: sum of 2 quarters · filed 2025-07-30 | $1.05M derived: sum of 3 quarters · filed 2025-07-30 | $1.80M derived: sum of 4 quarters · filed 2025-07-30 | |||
| 2023-05-31 | -$815.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | $113.00K derived: sum of 2 quarters · filed 2025-07-30 | $870.00K derived: sum of 3 quarters · filed 2025-07-30 | -$644.00K 10-K · filed 2025-07-30 | |||
| 2023-02-28 | $928.00K 10-Q · filed 2024-04-09 | $1.69M derived: sum of 2 quarters · filed 2024-04-09 | $171.00K 10-Q · filed 2024-04-09 | ||||
| 2022-11-30 | $757.00K 10-Q · filed 2024-01-09 | $757.00K 10-Q · filed 2024-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |